Ocrevus Zunovo Injection, Solution
Product Images NDC 50242-554

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ocrevus Zunovo (NDC 50242-554). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genentech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Ocrevus 01)

Figure 1 (Ocrevus 01)
The text suggests a comparison between two medications, REBIF 44 mg and EVUS 600 mg, in terms of reducing the risk of confirmed disability progression. A risk reduction of 40% is indicated with HR (95% CI) 0.60 (0.45, 0.81); p=0.0006. The proportion of patients having confirmed disability progression is shown to be 15.2% with REBIF and 9.8% with EVUS. The data also includes the number of patients at risk over time for each medication. The information is based on a study with sample sizes of 629 for REBIF and 627 for EVUS.*
FDA Label Image

Figure 2 (Ocrevus 02)

Figure 2 (Ocrevus 02)
The text provides information on a clinical trial comparing the efficacy of Placebo (n=244) and EVUS 600 mg (n=488). The results indicate a 24% reduction in the risk of CDP with EVUS compared to Placebo (HR=0.76, 95% CI: 0.59, 0.98; p=0.0321). The number of patients at risk is listed at various time points up to 216 weeks.*
FDA Label Image

Principal Display Panel (23 mL Vial Carton)

Principal Display Panel (23 mL Vial Carton)
This is a description of a medication called Ocrevus Zunovo™. It is an injection for subcutaneous use only, intended to be injected in the abdomen over approximately 10 minutes from a single-dose vial. It is important to discard any unused portion of the medication. Pharmacists are advised to dispense the accompanying Medication Guide to each patient along with one vial provided by Genentech. The NDC code for this medication is 50242-554-01.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.